Disclosures for "Diagnostic Utility and Prognostic Significance of Circulating Tumor Cell Assay CNSide in Patients With Suspicion for Leptomeningeal Metastases"
-
Dr. Louis has nothing to disclose.
-
Mr. Nageeb has nothing to disclose.
-
Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Daiichi-Sankyo. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Enclear. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Plus Therapuetics/Biocept. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure.
-
Dr. Rogawski has nothing to disclose.